| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |